CN112704582B - Preparation method of customizable regenerated porous nano-material 3D printed femoral head - Google Patents
Preparation method of customizable regenerated porous nano-material 3D printed femoral head Download PDFInfo
- Publication number
- CN112704582B CN112704582B CN202110096697.7A CN202110096697A CN112704582B CN 112704582 B CN112704582 B CN 112704582B CN 202110096697 A CN202110096697 A CN 202110096697A CN 112704582 B CN112704582 B CN 112704582B
- Authority
- CN
- China
- Prior art keywords
- femoral head
- powder
- biotin
- printing
- icariin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 41
- 239000002131 composite material Substances 0.000 claims abstract description 33
- 229960002685 biotin Drugs 0.000 claims abstract description 24
- 239000011616 biotin Substances 0.000 claims abstract description 24
- 238000007639 printing Methods 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000004005 microsphere Substances 0.000 claims abstract description 13
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 10
- 239000004626 polylactic acid Substances 0.000 claims abstract description 10
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 9
- 238000010146 3D printing Methods 0.000 claims abstract description 7
- 238000011068 loading method Methods 0.000 claims abstract description 7
- 239000002114 nanocomposite Substances 0.000 claims abstract description 6
- 238000002591 computed tomography Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 39
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical class [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 31
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 28
- 229920002292 Nylon 6 Polymers 0.000 claims description 25
- 210000004394 hip joint Anatomy 0.000 claims description 17
- 210000000988 bone and bone Anatomy 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 210000001624 hip Anatomy 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 9
- 229910021641 deionized water Inorganic materials 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 8
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 8
- 239000003462 bioceramic Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 229910052709 silver Inorganic materials 0.000 claims description 7
- 239000004332 silver Substances 0.000 claims description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 6
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000004372 laser cladding Methods 0.000 claims description 5
- 229910052786 argon Inorganic materials 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000008139 complexing agent Substances 0.000 claims description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- WCASXYBKJHWFMY-UHFFFAOYSA-N crotyl alcohol Chemical group CC=CCO WCASXYBKJHWFMY-UHFFFAOYSA-N 0.000 claims description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000003365 glass fiber Substances 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000002953 phosphate buffered saline Substances 0.000 claims description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000011856 silicon-based particle Substances 0.000 claims description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 3
- 230000003746 surface roughness Effects 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 2
- 239000001226 triphosphate Substances 0.000 claims description 2
- 235000011178 triphosphate Nutrition 0.000 claims description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- 208000005156 Dehydration Diseases 0.000 claims 1
- 239000001110 calcium chloride Substances 0.000 claims 1
- 235000011148 calcium chloride Nutrition 0.000 claims 1
- 229910001628 calcium chloride Inorganic materials 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 239000011265 semifinished product Substances 0.000 claims 1
- 238000005524 ceramic coating Methods 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 239000010936 titanium Substances 0.000 description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011540 hip replacement Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- GFKQSYHFCIGPDH-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;1h-pyrrole Chemical compound C=1C=CNC=1.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 GFKQSYHFCIGPDH-UFLZEWODSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 229910001111 Fine metal Inorganic materials 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000034655 secondary growth Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/32—Joints for the hip
- A61F2/36—Femoral heads ; Femoral endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/30769—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth madreporic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
- A61F2002/30948—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using computerized tomography, i.e. CT scans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2/30942—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
- A61F2002/30952—Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using CAD-CAM techniques or NC-techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/3097—Designing or manufacturing processes using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30985—Designing or manufacturing processes using three dimensional printing [3DP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00185—Ceramics or ceramic-like structures based on metal oxides
- A61F2310/00239—Ceramics or ceramic-like structures based on metal oxides containing zirconia or zirconium oxide ZrO2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明设计一种医用移植假体,尤其涉及一种定制可再生的多元多孔多层纳米复合物3D打印髋关节股骨头。The present invention designs a medical implant prosthesis, in particular to a customized and regenerable multi-component porous multi-layer nanocomposite 3D printing hip joint femoral head.
背景技术Background technique
髋关节是维持人体日常活动的重要关节之一,同时也较容易损伤从而引发疾病,目前髋关节置换术是治疗髋关节疾病的有效手段,近年来,随着3D打印技术的发展,学者们对人工髋关节假体的优化设计方面产生了极大的兴趣,很多专家和学者都为人工髋关节的发展都做出了卓越的贡献,并取得了显著成就,人工髋关节假体要求具有良好的生物相容性、灵活性、承载能力、稳定性及较小的摩擦磨损。随着材料科学和生物力学的不断进步,人工髋关节假体在材料、结构形状、固定方式、优化设计等方面的研究都有了很大的突破。The hip joint is one of the important joints to maintain the daily activities of the human body, and it is also easy to damage and cause diseases. At present, hip replacement surgery is an effective means to treat hip joint diseases. In recent years, with the development of 3D printing technology, scholars There has been great interest in the optimal design of artificial hip joint prostheses. Many experts and scholars have made outstanding contributions to the development of artificial hip joints and have achieved remarkable achievements. Artificial hip joint prostheses require good Biocompatibility, flexibility, load-carrying capacity, stability and less friction and wear. With the continuous progress of material science and biomechanics, great breakthroughs have been made in the research of artificial hip joint prostheses in terms of materials, structural shapes, fixation methods, and optimal design.
临床上髋关节置换术存在的问题可分为三个方面,包括患者自身身体状况、医生在手术过程中的操作技术和人工髋关节假体,影响人工髋关节假体的长期稳定性和使用寿命的两个主要因素是骨吸收和无菌性松动,研究发现手术后会伴有疼痛现象,究其主要原因主要是假体植入人体后产生了应力集中和应力遮挡。The clinical problems of hip replacement can be divided into three aspects, including the patient's own physical condition, the doctor's operation technique during the operation and the artificial hip prosthesis, which affect the long-term stability and service life of the artificial hip prosthesis. The two main factors are bone resorption and aseptic loosening. Studies have found that there will be pain after surgery. The main reason is that stress concentration and stress shielding occur after the prosthesis is implanted into the human body.
本发明打印出的髋关节股骨头与传统方法相比,采用体心立方体型结构打印,优化了力学性能、抗疲劳性能及稳定性,淫羊藿素作为成骨诱导活性物质已被广泛负载于骨科支架材料中,聚酰胺6拥有优良的韧性和耐摩擦性能及生物相容性,他们的加入提高了载药能力和缓释性能,能够刺激骨髓间充质干细胞参与假体周围的骨修复,实现髋关节股骨头的再生,避免二次手术的风险。与本发明相关的还有如下文献:Compared with the traditional method, the hip femoral head printed by the invention adopts the body-centered cubic structure to print, which optimizes the mechanical properties, anti-fatigue performance and stability. Among the orthopedic scaffold materials, polyamide 6 has excellent toughness, friction resistance and biocompatibility. Their addition improves drug-carrying capacity and sustained-release performance, and can stimulate bone marrow mesenchymal stem cells to participate in bone repair around the prosthesis. To achieve the regeneration of the femoral head of the hip joint, avoiding the risk of secondary surgery. Also relevant to the present invention are the following documents:
1.刘路坦.3D打印多孔钛金属植入物不同孔隙率对骨长入影响的实验研究[J].蚌埠医学院学报.2019.09:1153-1157.1. Liu Lutan. Experimental study on the effect of different porosity of 3D printed porous titanium implants on bone ingrowth [J]. Journal of Bengbu Medical College. 2019.09:1153-1157.
主要描述了通过观察不同孔隙率的3D打印多孔钛金属植入物在兔体内实验中的骨长入情况,评价多孔钛金属植入物不同的孔隙率对骨长入效果的影响。This paper mainly describes the effect of different porosity of porous titanium implants on the effect of bone ingrowth by observing the bone ingrowth of 3D printed porous titanium implants with different porosity in rabbit experiments.
2. 李姝博.3D打印髋关节假体多孔结构力学性能的数值仿真和实验研究[D].吉林大学.2020,06.2. Li Shubo. Numerical simulation and experimental study on mechanical properties of 3D printed hip prosthesis porous structure [D]. Jilin University. 2020,06.
主要描述了设置了4种不同的单元体结构并建立几何模型和有限元模型,模拟压缩实验进行有限元仿真分析,探究不同多孔结构力学性能的差异。It is mainly described that 4 different unit structures are set up, geometric models and finite element models are established, and the compression experiments are simulated to carry out finite element simulation analysis to explore the differences in mechanical properties of different porous structures.
3. 刘锌,杜―斌.多孔β磷酸三钙-聚吡咯-生物素-淫羊藿素微球复合支架促进骨髓间充质干细胞的募集[J]. 中国组织工程研究.2020.(34): 5532-5537.3. Liu Zin, Du Bin. Porous β-tricalcium phosphate-polypyrrole-biotin-icariin microsphere composite scaffold promotes the recruitment of bone marrow mesenchymal stem cells[J]. China Tissue Engineering Research.2020.(34 ): 5532-5537.
主要描述了多孔β磷酸三钙-聚吡咯-生物素复合支架较传统缓释支架进一步提高了载药能力及缓释性能,并具有良好的力学强度,同时可能具有更好的募集骨髓间充质干细胞参与支架周围骨修复的作用。It is mainly described that the porous β-tricalcium phosphate-polypyrrole-biotin composite scaffold has further improved drug-loading capacity and sustained-release performance compared with traditional sustained-release scaffolds, and has good mechanical strength, and may have better recruitment of bone marrow mesenchyme. Stem cells are involved in the role of bone repair around the scaffold.
4. 刘均环.钛合金表面激光熔覆制备含硼CaP生物陶瓷涂层[D].南华大学.2019.054. Liu Junhuan. Preparation of boron-containing CaP bioceramic coating by laser cladding on titanium alloy surface [D]. University of South China. 2019.05
主要描述了采用激光熔覆方法制备出不同含硼量的 CaP生物陶瓷涂层,研究了CaB6含量对熔覆层耐腐蚀性和生物活性的影响。This paper mainly describes the preparation of CaP bioceramic coatings with different boron content by laser cladding method, and studies the effect of CaB 6 content on the corrosion resistance and biological activity of the cladding layer.
5.胡雅菲.银/羟基磷灰石/聚酰胺6复合材料的制备及性能研究[D].太原理工大学.2018.065. Hu Yafei. Preparation and properties of silver/hydroxyapatite/polyamide 6 composites [D]. Taiyuan University of Technology. 2018.06
主要描述了用不同的络合剂通过溶液共混法制备了不同含量的Ag/HA/PA6复合材料,并对其结构、结晶性能、力学性能、摩擦性能等进行了分析研究。The Ag/HA/PA6 composites with different contents were prepared by solution blending method with different complexing agents, and their structure, crystallization properties, mechanical properties and friction properties were analyzed and studied.
6. Oshkour A A,Osman N A A,Davoodi M M,et al.Finite element analysison longitudinal and radial functionally graded femoral prosthesis[J].International Journal for Numerical Methods in Biomedical Engineering,2013,29(12): 1412-1427.6. Oshkour A A, Osman N A A, Davoodi M M, et al. Finite element analysis on longitudinal and radial functionally graded femoral prosthesis[J]. International Journal for Numerical Methods in Biomedical Engineering, 2013, 29(12): 1412-1427.
主要描述了不同几何参数对梯度股骨柄的影响,并且对梯度股骨柄进行了有限元分析,结果表明增加梯度指数会增加假体内的应变能,减小应力遮挡现象。The influence of different geometric parameters on the gradient femoral stem is mainly described, and the finite element analysis of the gradient femoral stem is carried out. The results show that increasing the gradient index will increase the strain energy in the prosthesis and reduce the stress shielding phenomenon.
7. Jetté B,Brailovski V,Dumas M,et al. Femoral stem incorporating adiamond cubic lattice structure:Design,manufacture and testing[J].Journal ofthe Mechanical Behavior of Biomedical Materials,2018,77:58-72.7. Jetté B, Brailovski V, Dumas M, et al. Femoral stem incorporating adiamond cubic lattice structure: Design, manufacturing and testing[J]. Journal of the Mechanical Behavior of Biomedical Materials, 2018, 77: 58-72.
主要讲述了采用有限元和实验相结合的方法对多孔髋关节假体进行研究,结果表明多孔型髋关节假体能够促进骨组织长入,并降低应力遮挡。This paper mainly describes the research on the porous hip joint prosthesis by the method of combining finite element and experiment. The results show that the porous hip joint prosthesis can promote the ingrowth of bone tissue and reduce the stress shielding.
8. Lim mahakhun S,O1oyede A,Chantarapanich N,et al.Altemative desgnsof load-sharing cobalt chromium graded femoral stems[J],Materials TodayCommunications,2017,12:1-10.8. Lim mahakhun S, O1oyede A, Chantarapanich N, et al.Altemative desgnsof load-sharing cobalt chromium graded femoral stems[J],Materials TodayCommunications,2017,12:1-10.
主要讲述了一种中间部位为梯度孔隙结构的髋关节假体,并对其力学性能和应力传递性能进行了有限元计算和三点弯曲实验研究。This paper mainly describes a hip joint prosthesis with a gradient pore structure in the middle, and the finite element calculation and three-point bending experiments are carried out on its mechanical properties and stress transfer properties.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种可定制再生多孔纳米材料3D打印股骨头的制备方法,通过该方法解决了人造骨骼成分利用率低、股骨头的强度、韧性及耐磨性不足的问题,多层结构所用的材料能够刺激骨细胞的修复与生长,使产品能满足人体骨骼亲和性的同时减少植入物的应力集中和应力遮挡,采用3D方法定制打印出来的产品更加符合人体的骨骼特性,其多孔结构的存在既保证了力学性能的同时也能实现骨骼的二次生长。The purpose of the present invention is to provide a preparation method for 3D printing femoral head with customizable regenerated porous nanomaterials, which solves the problems of low utilization rate of artificial bone components, insufficient strength, toughness and wear resistance of femoral heads, and the multi-layered The materials used in the structure can stimulate the repair and growth of bone cells, so that the products can meet the affinity of human bones while reducing the stress concentration and stress shielding of implants. The products printed by 3D method are more in line with the bone characteristics of the human body. The existence of its porous structure not only ensures the mechanical properties, but also realizes the secondary growth of bones.
本发明是通过以下技术方案来实施:The present invention is implemented through the following technical solutions:
用CT扫描人体两侧髋关节图像数据,根据CT图像通过镜像建立符合破损处髋关节股骨头的三维模型,以金属纳米混合物粉末材料混合银-羟基磷灰石-聚酰胺6作为3D打印的材料1,β磷酸三钙-聚吡咯-生物素复合材料作为3D打印的材料2,用材料1、2以体心立方体型多孔结构分别进行分层打印股骨头基体,然后在基体上载以淫羊藿素–生物素-聚乳酸微球,最后在打印体表面覆以生物陶瓷涂层并抛光,其具体方案如下:The image data of the hip joints on both sides of the human body were scanned with CT, and a three-dimensional model of the femoral head of the damaged hip joint was established by mirroring according to the CT image. 1. The β-tricalcium phosphate-polypyrrole-biotin composite material was used as the
1.骨骼建模1. Bone modeling
通过CT扫描设备对髋关节及髋关节股骨头破损处进行三维扫描获取图像数据,根据破损的髋关节股骨头,利用三维软件重新设计出可以移植股骨头的尺寸及形态。The CT scanning equipment is used to scan the hip joint and the damaged part of the hip femoral head to obtain image data. According to the damaged hip femoral head, the size and shape of the femoral head that can be transplanted are redesigned using 3D software.
2.金属纳米混合物粉末材料的制备2. Preparation of Metal Nanomix Powder Materials
取Ti粉末(纯度为99.9%),Mg颗粒(纯度为99.8%),Si颗粒(纯度99.8%)、Ca颗粒、Mo粉按摩尔量比为(30-50):(15-25):(30-40):(10-20):(0.1-0.3)混合均匀后放入高能球磨机进行处理,使其获得80-100nm晶粒尺寸超细金属纳米混合物粉末材料。Take Ti powder (purity of 99.9%), Mg particles (purity of 99.8%), Si particles (purity of 99.8%), Ca particles and Mo powder in a molar ratio of (30-50): (15-25): ( 30-40): (10-20): (0.1-0.3) After mixing evenly, put it into a high-energy ball mill for processing, so that it can obtain 80-100nm grain size ultra-fine metal nano-mixture powder material.
3. β磷酸三钙-聚吡咯-生物素复合材料的制备3. Preparation of β-tricalcium phosphate-polypyrrole-biotin composites
将去离子水、聚丙烯酸钠、β磷酸三钙、羟甲基丙烯、纤维素按质量分数比为(1-1.2):(0.8-1):(2-5):(1-1.5):(1.2-1.6)混合装入密闭容器中,加入等体积的0.1mol/L的吡咯和0.2mol/L聚合氯化铁混合搅拌35min,分离聚合物,用去离子水清洗,最后对成品进行干燥并放入球磨机处理得到晶粒尺寸在80-100nm的β磷酸三钙-聚吡咯-生物素复合材料。The ratio of deionized water, sodium polyacrylate, β-tricalcium phosphate, methylol propylene, and cellulose by mass fraction is (1-1.2): (0.8-1): (2-5): (1-1.5): (1.2-1.6) Mix them into a closed container, add equal volumes of 0.1mol/L pyrrole and 0.2mol/L polyferric chloride, mix and stir for 35min, separate the polymer, wash with deionized water, and finally dry the finished product And put it into a ball mill for processing to obtain a β-tricalcium phosphate-polypyrrole-biotin composite material with a grain size of 80-100 nm.
β磷酸三钙-聚吡咯-生物素复合骨骼表面粗糙而形态紧密规则,具有嵴状隆起,孔隙多,孔隙间连通性好,微观表面积大,扫描电镜下骨骼表面可见少量金属样晶体光泽,聚吡咯与磷酸三钙混合可赋予支架整体存在导电特性,其表面适合多种细胞黏附与生长。通过化学反应合成方法,以聚吡咯为亲和素,形成β磷酸三钙-聚吡咯-生物素结构,利用生物素多靶点结合能力提高支架与骨诱导因子的结合能力。The surface of β-tricalcium phosphate-polypyrrole-biotin composite bone is rough and regular in shape, with crest-like bulges, many pores, good connectivity between pores, large microscopic surface area, and a small amount of metal-like crystal luster can be seen on the bone surface under scanning electron microscope. The mixture of pyrrole and tricalcium phosphate can endow the scaffold with electrical conductivity as a whole, and its surface is suitable for the adhesion and growth of various cells. Through a chemical reaction synthesis method, polypyrrole is used as avidin to form a β-tricalcium phosphate-polypyrrole-biotin structure, and the multi-target binding ability of biotin is used to improve the binding ability of the scaffold to osteoinductive factors.
4. 淫羊藿素–生物素-聚乳酸微球的制备4. Preparation of icariin–biotin–polylactic acid microspheres
将等量的生物素、淫羊藿素、1-羟基苯并三唑和4-二甲氨基吡啶置于聚氨基酸溶液中,室温搅拌,冷却至0℃,进行脱水处理后将温度升至24-26℃进行充分反应,用去离子水洗涤,将复合物悬浮于无水乙醇中,进行加热过滤,再用热无水乙醇洗涤2次,干燥后获得淫羊藿素-生物素复合物。Put equal amounts of biotin, icariin, 1-hydroxybenzotriazole and 4-dimethylaminopyridine in the polyamino acid solution, stir at room temperature, cool to 0 °C, and then increase the temperature to 24 °C after dehydration. Fully react at -26°C, wash with deionized water, suspend the complex in absolute ethanol, filter by heating, wash twice with hot absolute ethanol, and dry to obtain the icariin-biotin complex.
将聚乳酸-羟基乙酸共聚物、聚氨基酸、蒸馏水、淫羊藿素-生物素复合物按质量分数为(24.6-25.3):(24.8-25.4):(1.8-2.6):(4.8-5.3)混合,超声15 min,变幅杆振动频率40-100kHz,振幅30-100μm,将10g/L聚乙烯醇溶液缓慢滴入上述混合溶液进行乳化操作,超声15 min后得到淫羊藿素-生物素/聚乳酸-羟基乙酸共聚物复乳,最后高速12000r/min离心20min,过滤,磷酸缓冲盐溶液清洗2次,将所得混悬液离心取出沉淀,放入冷冻干燥机干燥,得到淫羊藿素-生物素-聚乳酸微球,微球直径在2-20μm范围。The polylactic acid-glycolic acid copolymer, polyamino acid, distilled water, and icariin-biotin complex by mass fraction are (24.6-25.3): (24.8-25.4): (1.8-2.6): (4.8-5.3) Mixing, ultrasonic for 15 min, horn vibration frequency 40-100 kHz, amplitude 30-100 μm, slowly drop 10 g/L polyvinyl alcohol solution into the above mixed solution for emulsification operation, ultrasonic for 15 min to obtain icariin-biotin / Polylactic acid-glycolic acid copolymer double emulsion, finally centrifuged at a high speed of 12000r/min for 20min, filtered, washed twice with phosphate buffered saline, centrifuged the obtained suspension to remove the precipitate, put it in a freeze dryer to dry, and obtained icariin - Biotin-polylactic acid microspheres, the diameter of the microspheres is in the range of 2-20 μm.
5. 银-羟基磷灰石-聚酰胺6复合材料的制备5. Preparation of silver-hydroxyapatite-polyamide 6 composites
利用络合剂配位溶解的方法制备HA/PA6复合材料,首先在密闭干燥容器中将CaCl2和C2H5OH按摩尔配比为1:5进行混合搅拌10min,温度设置在68-72℃,将羟基磷灰石(HA)的含量设置在40%与聚酰胺6(PA6)混合后放入上述容器中搅拌20min,得到HA/PA6复合材料,然后选用等离子体还原法给上述HA/PA6复合材料载银,将银含量设置在0.6%与HA/PA6复合材料进行混合,再加入5-20%的玻璃纤维进行混合搅拌,最后对成品进行干燥并放入球磨机处理得到晶粒尺寸在80-100nm的Ag/HA/PA6的复合材料。The HA/PA6 composite material was prepared by the method of complexing and dissolving the complexing agent. First, the CaCl 2 and C 2 H 5 OH were mixed and stirred at a molar ratio of 1:5 in a closed drying container for 10 minutes, and the temperature was set at 68-72 ℃, the content of hydroxyapatite (HA) is set at 40% and mixed with polyamide 6 (PA6), then placed in the above container and stirred for 20min to obtain HA/PA6 composite material, and then plasma reduction method is used to give the above HA/PA6 composite material. The PA6 composite material is loaded with silver, the silver content is set at 0.6% and mixed with the HA/PA6 composite material, and then 5-20% glass fiber is added for mixing and stirring, and finally the finished product is dried and placed in a ball mill to obtain a grain size of 80-100nm Ag/HA/PA6 composite.
6.利用三维打印技术打印股骨头6. Using 3D printing technology to print the femoral head
将金属纳米混合物粉末材料与银-羟基磷灰石-聚酰胺6复合材料粉末分别按质量分数比为3:1进行充分混合,将获得的粉料命名为材料1,将β磷酸三钙-聚吡咯-生物素粉末命名为材料2,淫羊藿素–生物素-聚乳酸微球粉末为材料3,至此准备工作完成。The metal nano-mixture powder material and the silver-hydroxyapatite-polyamide 6 composite material powder were fully mixed according to the mass fraction ratio of 3:1, and the obtained powder was named as
将模拟出的三维模型导入3D打印机中,采用选择性激光熔化技术( Selectivelaser melting, SLM )用材料1在辅助支架上打印出直径为2-2.2cm的球状体,作为股骨头“内核”,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,打印的结构形态设为体心立方体型多孔结构,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,然后用材料2在股骨“内核”的基础上随着辅助支架的转动和移动继续打印6-8mm厚,作为第二层,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,采用体心立方型多孔结构进行打印,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,再用SLM技术用材料1在材料2的基础上在打印1-1.2cm厚,作为第三层,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,采用体心立方型多孔结构进行打印,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,打印过程中,添加超声振动变幅杆,振动频率80-100kHz,振幅20-150μm,工具头距激光头轴线40-50mm,至此完成股骨头的半成品,将半成品股骨头从辅助支架上取下放入离心管,加入材料3的悬液以及10%明胶,低速离心10 min,冷冻24 h,进行股骨头载球处理,再将羟基磷灰石(HA)、β磷酸三钙及CaB6粉末用电子天平按以47:48:5分别称量,并将三种粉末混合用球磨机研磨充分,HA的粉末粒度为30nm,纯度为99.9%,CaB6粉末粒度为45nm,β磷酸三钙粉末粒度为30nm,纯度为99.8%,采用0.1%的异丙醇作为粘结剂混合搅拌5min,将上述混合粉末制备成具有一定粘度的膏体涂满股骨头表面,预置层粉末厚度为4-6mm,在室温条件下静置24h后,放入真空干燥箱中干燥2h,真空干燥箱温度设置为45℃,采用激光熔覆的方法将股骨头与膏体结合,设置激光功率P=1.2KW,扫描速度V=15mm/s,光斑直径为3.0mm,搭接率为40%,氩气流速为10L/min,制备出生物陶瓷涂层,最后对成型产品进行抛光处理,降低材料表面粗糙度。The simulated 3D model was imported into a 3D printer, and a spheroid with a diameter of 2-2.2 cm was printed on the auxiliary support using the selective laser melting technology (Selectivelaser melting, SLM), which was used as the "core" of the femoral head. The diameter is set to 120-150nm, the printing speed is set to 80-100mm/min, the printed structure is set to a body-centered cubic porous structure, the pore size is set to 600-650μm, the porosity is set to 45%-55%, and the pillar diameter is set to Design at 1000-1200μm, and then use
附图说明:Description of drawings:
图1为3D打印髋关节股骨头的材料分层示意图,图1中1为金属纳米复合材料内核;2为β磷酸三钙-聚吡咯-生物素复合材料;3为金属纳米复合材料;4为生物陶瓷涂层。Figure 1 is a schematic diagram of the material layering of the 3D printed hip femoral head. In Figure 1, 1 is a metal nanocomposite core; 2 is a β-tricalcium phosphate-polypyrrole-biotin composite; 3 is a metal nanocomposite; 4 is a Bioceramic coating.
具体实施方式:Detailed ways:
第一步:通过CT扫描设备对髋关节及髋关节股骨头破损处进行三维扫描获取图像数据,根据破损的髋关节股骨头,利用三维软件重新设计出可以移植髋关节股骨头的尺寸及形态。Step 1: Use CT scanning equipment to scan the hip joint and the damaged part of the hip femoral head to obtain image data. According to the damaged hip femoral head, use 3D software to redesign the size and shape of the hip femoral head that can be transplanted.
第二步:取Ti粉末(纯度为99.9%),Mg颗粒(纯度为99.8%),Si颗粒(纯度99.8%)、Ca颗粒、Mo粉按摩尔量比为(30-50):(15-25):(30-40):(10-20):(0.1-0.3)混合均匀后放入高能球磨机进行处理,使其获得80-100nm晶粒尺寸超细复合粉。Step 2: Take Ti powder (purity 99.9%), Mg particles (purity 99.8%), Si particles (purity 99.8%), Ca particles, Mo powder in molar ratio (30-50): (15- 25): (30-40): (10-20): (0.1-0.3) After mixing evenly, put it into a high-energy ball mill for processing to obtain 80-100nm grain size ultra-fine composite powder.
第三步:将去离子水、聚丙烯酸钠、β磷酸三钙、羟甲基丙烯、纤维素按质量分数比为(1-1.2):(0.8-1):(2-5):(1-1.5):(1.2-1.6)混合装入密闭容器中,加入等体积的0.1mol/L的吡咯和0.2mol/L聚合氯化铁混合搅拌35min,分离聚合物,用去离子水清洗,最后对成品进行干燥并放入球磨机处理得到晶粒尺寸在80-100nm的β磷酸三钙-聚吡咯-生物素复合材料。The third step: deionized water, sodium polyacrylate, β-tricalcium phosphate, methylol propylene, and cellulose are in a mass fraction ratio of (1-1.2): (0.8-1): (2-5): (1 -1.5): (1.2-1.6) Mix and put into a closed container, add equal volume of 0.1mol/L pyrrole and 0.2mol/L polyferric chloride, mix and stir for 35min, separate the polymer, wash with deionized water, and finally The finished product is dried and processed in a ball mill to obtain a β-tricalcium phosphate-polypyrrole-biotin composite material with a grain size of 80-100 nm.
第四步:将等量的生物素、淫羊藿素、1-羟基苯并三唑和4-二甲氨基吡啶置于聚氨基酸溶液中,室温搅拌,冷却至0℃,进行脱水处理后将温度升至24-26℃进行充分反应,用去离子水洗涤,将复合物悬浮于无水乙醇中,进行加热过滤,再用热无水乙醇洗涤2次,干燥后获得淫羊藿素-生物素复合物。The fourth step: put equal amounts of biotin, icariin, 1-hydroxybenzotriazole and 4-dimethylaminopyridine in the polyamino acid solution, stir at room temperature, cool to 0°C, and dehydrate the solution. The temperature was raised to 24-26 °C for a full reaction, washed with deionized water, the complex was suspended in absolute ethanol, filtered by heating, washed twice with hot absolute ethanol, and dried to obtain icariin-biological element complex.
将聚乳酸-羟基乙酸共聚物、聚氨基酸、蒸馏水、淫羊藿素-生物素复合物按质量分数为(24.6-25.3):(24.8-25.4):(1.8-2.6):(4.8-5.3)混合,超声15 min,变幅杆振动频率40-100kHz,振幅30-100μm,将10g/L聚乙烯醇溶液缓慢滴入上述混合溶液进行乳化操作,超声15 min后得到淫羊藿素-生物素/聚乳酸-羟基乙酸共聚物复乳,最后高速12000r/min离心20min,过滤,磷酸缓冲盐溶液清洗2次,将所得混悬液离心取出沉淀,放入冷冻干燥机干燥,得到淫羊藿素-生物素-聚乳酸微球,微球直径在2-20μm范围。The polylactic acid-glycolic acid copolymer, polyamino acid, distilled water, and icariin-biotin complex by mass fraction are (24.6-25.3): (24.8-25.4): (1.8-2.6): (4.8-5.3) Mixing, ultrasonic for 15 min, horn vibration frequency 40-100 kHz, amplitude 30-100 μm, slowly drop 10 g/L polyvinyl alcohol solution into the above mixed solution for emulsification operation, ultrasonic for 15 min to obtain icariin-biotin / Polylactic acid-glycolic acid copolymer double emulsion, finally centrifuged at a high speed of 12000r/min for 20min, filtered, washed twice with phosphate buffered saline, centrifuged the obtained suspension to remove the precipitate, put it in a freeze dryer to dry, and obtained icariin - Biotin-polylactic acid microspheres, the diameter of the microspheres is in the range of 2-20 μm.
第六步:利用络合剂配位溶解的方法制备HA/PA6复合材料,首先在密闭干燥容器中将CaCl2和C2H5OH按摩尔配比为1:5进行混合搅拌10min,温度设置在68-72℃,将羟基磷灰石(HA)的含量设置在40%与聚酰胺6(PA6)混合后放入上述容器中搅拌20min,得到HA/PA6复合材料,然后选用等离子体还原法给上述HA/PA6复合材料载银,将银含量设置在0.6%与HA/PA6复合材料进行混合,再加入5-20%的玻璃纤维进行混合搅拌,最后对成品进行干燥并放入球磨机处理得到晶粒尺寸在80-100nm的Ag/HA/PA6的复合材料。The sixth step: prepare the HA/PA6 composite material by the method of complexing and dissolving the complexing agent, firstly, in a closed drying container, the molar ratio of CaCl 2 and C 2 H 5 OH is 1:5 for mixing and stirring for 10 minutes, and the temperature is set At 68-72 ℃, the content of hydroxyapatite (HA) is set at 40%, mixed with polyamide 6 (PA6), and then placed in the above container and stirred for 20 minutes to obtain HA/PA6 composite material, and then the plasma reduction method is used. The above HA/PA6 composite material is loaded with silver, the silver content is set at 0.6% and mixed with the HA/PA6 composite material, and then 5-20% of glass fiber is added for mixing and stirring, and finally the finished product is dried and put into a ball mill for processing. Ag/HA/PA6 composites with a grain size of 80-100 nm.
第七步:将金属纳米混合物粉末材料与银-羟基磷灰石-聚酰胺6复合材料分别按质量分数比为3:1进行充分混合,将获得的粉料命名为材料1,将β磷酸三钙-聚吡咯-生物素命名为材料2,淫羊藿素–生物素-聚乳酸微球为材料3,至此准备工作完成。The seventh step: the metal nano-mixture powder material and the silver-hydroxyapatite-polyamide 6 composite material are fully mixed according to the mass fraction ratio of 3:1, the obtained powder is named as
将模拟出的三维模型导入3D打印机中,采用选择性激光熔化技术( Selectivelaser melting, SLM )用材料1在辅助支架上打印出直径为2-2.2cm的球状体,作为股骨头“内核”,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,打印的结构形态设为体心立方体型多孔结构,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,然后用材料2在股骨“内核”的基础上随着辅助支架的转动和移动继续打印6-8mm厚,作为第二层,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,采用体心立方型多孔结构进行打印,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,再用SLM技术用材料1在材料2的基础上在打印1-1.2cm厚,作为第三层,喷头直径设置为120-150nm,设置打印速度为80-100mm/min,采用体心立方型多孔结构进行打印,孔隙尺寸设置在600-650μm,孔隙率设置在45%-55%,支柱直径设计在1000-1200μm,打印过程中,添加超声振动变幅杆,振动频率80-100kHz,振幅20-150μm,工具头距激光头轴线40-50mm,至此完成股骨头的半成品,将半成品股骨头从辅助支架上取下放入离心管,加入材料3的悬液以及10%明胶,低速离心10 min,冷冻24 h,进行股骨头载球处理。The simulated 3D model was imported into a 3D printer, and a spheroid with a diameter of 2-2.2 cm was printed on the auxiliary support using the selective laser melting technology (Selectivelaser melting, SLM), which was used as the "core" of the femoral head. The diameter is set to 120-150nm, the printing speed is set to 80-100mm/min, the printed structure is set to a body-centered cubic porous structure, the pore size is set to 600-650μm, the porosity is set to 45%-55%, and the pillar diameter is set to Design at 1000-1200μm, and then use
第八步:对载球处理后的股骨头进行去应力处理,再将羟基磷灰石(HA)、β磷酸三钙及CaB6粉末用电子天平按以47:48:5分别称量,并将三种粉末混合用球磨机研磨充分,得到HA的粉末粒度为30nm,纯度为99.9%,CaB6粉末粒度为45nm,β磷酸三钙粉末粒度为30nm,纯度为99.8%,采用0.1%的异丙醇作为粘结剂混合搅拌5min,将上述混合粉末制备成具有一定粘度的膏体涂满股骨头表面,预置层粉末厚度为4-6mm,在室温条件下静置24h后,放入真空干燥箱中干燥2h,真空干燥箱温度设置为45℃,采用激光熔覆的方法将股骨头与膏体结合,设置激光功率P=1.2KW,扫描速度V=15mm/s,光斑直径为3.0mm,搭接率为40%,氩气流速为10L/min,制备出生物陶瓷涂层,最后对成型产品进行抛光处理,降低材料表面粗糙度。Step 8: Relieve the femoral head after the ball loading treatment, and then weigh the hydroxyapatite (HA), β-tricalcium phosphate and CaB 6 powders with an electronic balance at a ratio of 47:48:5, respectively, and weigh them. Mix the three powders and grind them thoroughly with a ball mill to obtain HA powder with a particle size of 30 nm and a purity of 99.9%, CaB 6 powder with a particle size of 45 nm, beta tricalcium phosphate powder with a particle size of 30 nm and a purity of 99.8%, using 0.1% isopropyl Alcohol is used as a binder to mix and stir for 5 minutes, and the above mixed powder is prepared into a paste with a certain viscosity and coated on the surface of the femoral head. The thickness of the powder in the preset layer is 4-6 mm. After standing at room temperature for 24 hours, put it into vacuum drying Dry in the box for 2h, set the temperature of the vacuum drying box to 45℃, combine the femoral head with the paste by laser cladding, set the laser power P=1.2KW, the scanning speed V=15mm/s, the spot diameter is 3.0mm, The overlap ratio is 40%, and the flow rate of argon gas is 10L/min to prepare the bioceramic coating. Finally, the molded product is polished to reduce the surface roughness of the material.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110096697.7A CN112704582B (en) | 2021-01-25 | 2021-01-25 | Preparation method of customizable regenerated porous nano-material 3D printed femoral head |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110096697.7A CN112704582B (en) | 2021-01-25 | 2021-01-25 | Preparation method of customizable regenerated porous nano-material 3D printed femoral head |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112704582A CN112704582A (en) | 2021-04-27 |
CN112704582B true CN112704582B (en) | 2022-05-06 |
Family
ID=75549536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110096697.7A Active CN112704582B (en) | 2021-01-25 | 2021-01-25 | Preparation method of customizable regenerated porous nano-material 3D printed femoral head |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112704582B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118403220B (en) * | 2024-07-04 | 2024-10-29 | 上海埃度医疗器械科技有限公司 | Composite material for promoting periosteum repair and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105105875A (en) * | 2015-08-04 | 2015-12-02 | 西安交通大学 | Biomimetic artificial hip joint with internal growth function |
CN108014369A (en) * | 2018-01-24 | 2018-05-11 | 山东建筑大学 | A kind of preparation method of the compound bone material of renewable titanium-based |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6423796A (en) * | 1995-08-29 | 1997-03-06 | Johnson & Johnson Professional, Inc. | Bone prosthesis with protected coating for penetrating bone intergrowth |
US8843229B2 (en) * | 2012-07-20 | 2014-09-23 | Biomet Manufacturing, Llc | Metallic structures having porous regions from imaged bone at pre-defined anatomic locations |
CN104644289B (en) * | 2015-03-24 | 2016-09-14 | 国家康复辅具研究中心 | Preparation method of artificial bone prosthesis with double void |
CN104784760B (en) * | 2015-03-25 | 2017-05-17 | 华南协同创新研究院 | Low-elasticity-modulus integrated titanium-based femoral stem and preparation method thereof |
CN106420119B (en) * | 2016-11-29 | 2017-10-31 | 淮阴工学院 | A kind of manufacturing process of high antibiotic property titanium alloy artificial hip joint |
CN107899083B (en) * | 2017-11-29 | 2020-05-26 | 南宁越洋科技有限公司 | Preparation method of super-wear-resistant high-toughness bioactive artificial hip joint |
CN108478859B (en) * | 2018-03-06 | 2020-08-21 | 北京科技大学 | A method for preparing hydroxyapatite-biomedical alloy implant by 3D cold printing |
CN109330744B (en) * | 2018-09-27 | 2020-08-25 | 山东建筑大学 | A custom degradable multi-layered nanocomposite 3D printed prosthetic finger phalanges |
CN109316265A (en) * | 2018-11-15 | 2019-02-12 | 西安迈瑞克增材技术有限公司 | A kind of biodegradable neck Invasive lumbar fusion device and preparation method thereof |
CN109771698B (en) * | 2019-03-25 | 2021-06-25 | 石永新 | Bone scaffold complex and preparation method thereof |
CN110403736A (en) * | 2019-08-09 | 2019-11-05 | 常州市第二人民医院 | A kind of super porous titanium alloy of 3D printing facilitates bone surface method of modifying |
CN111068110B (en) * | 2019-11-25 | 2021-08-17 | 中国科学院长春应用化学研究所 | A 3D printed degradable composite scaffold, its preparation method, and a loaded composite scaffold |
-
2021
- 2021-01-25 CN CN202110096697.7A patent/CN112704582B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105105875A (en) * | 2015-08-04 | 2015-12-02 | 西安交通大学 | Biomimetic artificial hip joint with internal growth function |
CN108014369A (en) * | 2018-01-24 | 2018-05-11 | 山东建筑大学 | A kind of preparation method of the compound bone material of renewable titanium-based |
Also Published As
Publication number | Publication date |
---|---|
CN112704582A (en) | 2021-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Biomimetic design strategy of complex porous structure based on 3D printing Ti-6Al-4V scaffolds for enhanced osseointegration | |
Yang et al. | Additive manufacturing of bone scaffolds | |
Zheng et al. | Promotion of osseointegration between implant and bone interface by titanium alloy porous scaffolds prepared by 3D printing | |
Baino et al. | Bioceramics and scaffolds: a winning combination for tissue engineering | |
Mahammod et al. | Investigation of physico-mechanical behavior, permeability and wall shear stress of porous HA/PMMA composite bone scaffold | |
CN112966411B (en) | Medical implant based on body representative unit stress and preparation method and application thereof | |
Wang et al. | Biomimetic modification of porous TiNbZr alloy scaffold for bone tissue engineering | |
CN109133907A (en) | A kind of artificial bone and preparation method thereof comprising hydroxyapatite crystal whisker and biphase calcium phosphor | |
Hadagalli et al. | Faster biomineralization and tailored mechanical properties of marine-resource-derived hydroxyapatite scaffolds with tunable interconnected porous architecture | |
Wang et al. | Indirect 3D printing technology for the fabrication of customised β-TCP/chitosan scaffold with the shape of rabbit radial head—an in vitro study | |
CN107233619A (en) | A kind of Porous titanium bone implant material of functionalization and preparation method thereof | |
CN108863332A (en) | A kind of three-dimensional porous calcium silicates bone bracket and preparation method thereof with micro-nano structure surface | |
CN109620475A (en) | One kind being implanted into preparation based on CT data individuation porous titanium alloy shin bone | |
CN112704582B (en) | Preparation method of customizable regenerated porous nano-material 3D printed femoral head | |
CN113274550A (en) | Vascularized bone bionic multifunctional tissue engineering scaffold with anti-inflammatory effect and preparation method thereof | |
CN101716368A (en) | Porous titanium artificial bone for restoring bone tissue and preparation method thereof | |
Shao et al. | Effects of hydroxyapatite-coated porous titanium scaffolds functionalized by exosomes on the regeneration and repair of irregular bone | |
Pradeep et al. | 3D printing of shrimp derived chitosan with HAp as a bio-composite scaffold | |
CN115444625A (en) | Method for 3D printing of positive and negative Poisson's ratio hexagonal porous composite bone scaffold | |
CN116158891A (en) | Segmental bone composite porous scaffold and preparation method thereof | |
CN208243822U (en) | A kind of 3D printing composite magnetic metallic support | |
Verma et al. | A review on the microstructural and biomedical properties of implants manufactured using additive manufacturing | |
CN112028620A (en) | A kind of porous hydroxyapatite bioactive material and its preparation method and application | |
CN115090903B (en) | A medical implant based on molecular sieve functional unit and its preparation method | |
CN109432493B (en) | Nano-hydroxyapatite coating porous titanium scaffold and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |